A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
Context Therapeutics Inc.
Context Therapeutics Inc.
Centre Leon Berard
Sahlgrenska University Hospital
Xencor, Inc.
University Hospital, Clermont-Ferrand
Indiana University
BioNTech SE
Loma Linda University
Wake Forest University Health Sciences
Duke University
City of Hope Medical Center
University Medical Center Groningen
West China Hospital
University of Arizona
Jonsson Comprehensive Cancer Center
Western University, Canada
Columbia University
University of California, Irvine
University Health Network, Toronto
Fudan University
University Medical Center Groningen
Second Affiliated Hospital of Guangzhou Medical University
Royal Marsden NHS Foundation Trust
Dana-Farber Cancer Institute